Hanne Sand Hansen

5.6k total citations · 2 hit papers
71 papers, 3.6k citations indexed

About

Hanne Sand Hansen is a scholar working on Otorhinolaryngology, Oncology and Surgery. According to data from OpenAlex, Hanne Sand Hansen has authored 71 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Otorhinolaryngology, 27 papers in Oncology and 24 papers in Surgery. Recurrent topics in Hanne Sand Hansen's work include Head and Neck Cancer Studies (29 papers), Head and Neck Surgical Oncology (11 papers) and Ear and Head Tumors (10 papers). Hanne Sand Hansen is often cited by papers focused on Head and Neck Cancer Studies (29 papers), Head and Neck Surgical Oncology (11 papers) and Ear and Head Tumors (10 papers). Hanne Sand Hansen collaborates with scholars based in Denmark, Norway and Sweden. Hanne Sand Hansen's co-authors include Jens Overgaard, Lena Specht, Lars Bastholt, Marie Overgaard, Cai Grau, Jørgen Johansen, Lisbeth Juhler Andersen, Elo Andersen, Olfred Hansen and Jens Jørgen Thorn and has published in prestigious journals such as The Lancet, Cancer and Annals of Neurology.

In The Last Decade

Hanne Sand Hansen

70 papers receiving 3.5k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial

2003 481 citations Jens Overgaard, Hanne Sand Hansen et al. The Lancet profile →
Pre‐operative radiotherapy prolongs survival in operable esophageal carcinoma: A randomized, multicenter study of pre‐operative radiotherapy and chemotherapy. The second scandinavian trial in esophageal cancer

1992 473 citations Hanne Sand Hansen, Hans Modig et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hanne Sand Hansen Denmark	32	1.7k	1.6k	1.5k	1.3k	323	71	3.6k
F. Eschwège France	30	2.1k 1.2×	1.4k 0.9×	1.3k 0.9×	1.4k 1.1×	388 1.2×	106	3.3k
Lisbeth Juhler Andersen Denmark	26	1.3k 0.7×	751 0.5×	1.2k 0.8×	963 0.8×	240 0.7×	51	2.3k
Anne Kirkpatrick Belgium	14	1.6k 0.9×	2.5k 1.6×	1.9k 1.3×	1.9k 1.5×	270 0.8×	16	4.4k
Kathryn M. Greven United States	34	1.3k 0.8×	804 0.5×	1.1k 0.7×	857 0.7×	602 1.9×	92	3.6k
B Luboïnski France	40	3.0k 1.8×	1.8k 1.1×	3.2k 2.1×	1.9k 1.5×	417 1.3×	136	6.0k
Kenneth S. Hu United States	25	1.0k 0.6×	904 0.6×	1.0k 0.7×	987 0.8×	251 0.8×	133	2.6k
Ding-Jen Lee United States	8	1.5k 0.9×	1.1k 0.7×	2.1k 1.4×	878 0.7×	143 0.4×	12	2.8k
Nobukazu Fuwa Japan	28	1.1k 0.6×	1.3k 0.8×	918 0.6×	936 0.7×	322 1.0×	183	2.7k
Jean-Louis Lefèbvre France	5	2.1k 1.2×	1.2k 0.7×	2.9k 1.9×	1.4k 1.1×	152 0.5×	6	3.7k
Harold E. Kim United States	15	1.7k 1.0×	1.1k 0.7×	2.5k 1.6×	1.2k 1.0×	216 0.7×	17	3.4k

Countries citing papers authored by Hanne Sand Hansen

Since Specialization

Citations

This map shows the geographic impact of Hanne Sand Hansen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanne Sand Hansen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanne Sand Hansen more than expected).

Fields of papers citing papers by Hanne Sand Hansen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanne Sand Hansen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanne Sand Hansen. The network helps show where Hanne Sand Hansen may publish in the future.

Co-authorship network of co-authors of Hanne Sand Hansen

This figure shows the co-authorship network connecting the top 25 collaborators of Hanne Sand Hansen. A scholar is included among the top collaborators of Hanne Sand Hansen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanne Sand Hansen. Hanne Sand Hansen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Overgaard, Jens, Camilla Molich Hoff, Hanne Sand Hansen, et al.. (2018). DAHANCA 10 – Effect of darbepoetin alfa and radiotherapy in the treatment of squamous cell carcinoma of the head and neck. A multicenter, open-label, randomized, phase 3 trial by the Danish head and neck cancer group. Radiotherapy and Oncology. 127(1). 12–19. 21 indexed citations

Hoff, Camilla Molich, Hanne Sand Hansen, Marie Overgaard, et al.. (2010). The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy – Results from the randomized DAHANCA 5 study. Radiotherapy and Oncology. 98(1). 28–33. 52 indexed citations

Melgaard, B, et al.. (2009). MISONIDAZOLE NEUROPATHY:. Acta Neurologica Scandinavica. 65(S90). 107–108.

Madsen, Anders Rørbæk, Maria Gry Gundgaard, Camilla Molich Hoff, et al.. (2008). Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001. Head & Neck. 30(10). 1332–1338. 59 indexed citations

Engström, Per, et al.. (2005). In vivo dose verification of IMRT treated head and neck cancer patients. Acta Oncologica. 44(6). 572–578. 19 indexed citations

Theilgaard, Sune A., et al.. (2003). Esthesioneuroblastoma: a Danish Demographic Study of 40 Patients Registered Between 1978 and 2000. Acta Oto-Laryngologica. 123(3). 433–439. 76 indexed citations

Overgaard, Jens, Hanne Sand Hansen, Lena Specht, et al.. (2003). Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial. The Lancet. 362(9388). 933–940. 481 indexed citations breakdown →

Johansen, Jørgen, Annika Eigtved, Christian von Buchwald, Sune A. Theilgaard, & Hanne Sand Hansen. (2002). Implication of 18F‐Fluoro‐2‐Deoxy‐D‐Glucose Positron Emission Tomography on Management of Carcinoma of Unknown Primary in the Head and Neck: A Danish Cohort Study. The Laryngoscope. 112(11). 2009–2014. 71 indexed citations

Christensen, Lise, M Blichert-Toft, M. R. Brandt, et al.. (2000). Thyroperoxidase (TPO) immunostaining of the solitary cold thyroid nodule. Clinical Endocrinology. 53(2). 161–169. 38 indexed citations

10.

Zimmermann‐Belsing, Tina, Lise Christensen, Hanne Sand Hansen, et al.. (2000). A Case of Sarcoidosis and Sarcoid Granuloma, Papillary Carcinoma, and Graves' Disease in the Thyroid Gland. Thyroid. 10(3). 275–278. 21 indexed citations

11.

Overgaard, Jens, Hanne Sand Hansen, Marie Overgaard, et al.. (1999). Randomized trial evaluating the role of blood transfusion prior to radiotherapy in 414 patients with head and neck carcinoma. A multicenter study by the Danish Head and Neck Cancer Study Group (DAHANCA). European Journal of Cancer. 35. S161–S161. 1 indexed citations

12.

Therkildsen, Marianne Hamilton, Maria E. Christensen, Lisbeth Juhler Andersen, Torben Schiødt, & Hanne Sand Hansen. (1998). Salivary Gland Carcinomas: Prognostic Factors. Acta Oncologica. 37(7-8). 701–713. 64 indexed citations

13.

Overgaard, Jens, Hanne Sand Hansen, Marie Overgaard, et al.. (1997). 106 Conventional radiotherapy as primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week-report from the Dahanca 7 trial. International Journal of Radiation Oncology*Biology*Physics. 39(2). 188–188. 36 indexed citations

14.

Lewin, Freddi, Lena Damber, Håkan Jönsson, et al.. (1997). Neoadjuvant chemotherapy with cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the head and neck: a randomized Phase III study. Radiotherapy and Oncology. 43(1). 23–28. 42 indexed citations

15.

Christensen, Maria E., Hanne Sand Hansen, Steen Seier Poulsen, P. Bretlau, & Ebba Nexø. (1996). Imiminohistochemical and Quantitative Changes in Salivary EGF, Amylase and Haptocorrin following Radiotherapy for Oral Cancer. Acta Oto-Laryngologica. 116(1). 137–143. 20 indexed citations

16.

Schaadt, Bente Krogsgaard, Ulla Feldt‐Rasmussen, Bente Rasmusson, et al.. (1995). Assessment of the Influence of Thyroglobulin (Tg) Autoantibodies and Other Interfering Factors on the Use of Serum Tg as Tumor Marker in Differentiated Thyroid Carcinoma. Thyroid. 5(3). 165–170. 40 indexed citations

17.

Lindeløv, Birgit, et al.. (1992). Squamous Cell Carcinoma of the Oropharynx: Results of primary radiotherapy. Acta Oncologica. 31(3). 341–345. 6 indexed citations

18.

Bentzen, Jens, et al.. (1991). Nasopharyngeal carcinoma treated at the finsen institute, Copenhagen 1965‐1985: Survival and some prognostic factors. The Laryngoscope. 101(6). 635–642. 7 indexed citations

19.

Overgaard, Jens, Hanne Sand Hansen, A. P. Andersen, et al.. (1989). Misonidazole combined with split-course radiotherapy in the treatment of invasive carcinoma of larynx and pharynx: Report from the DAHANCA 2 study. International Journal of Radiation Oncology*Biology*Physics. 16(4). 1065–1068. 160 indexed citations

20.

Melgaard, B, Hanne Sand Hansen, Z Kamieniecka, et al.. (1982). Misonidazole neuropathy: A clinical, electrophysiological and histological study. Annals of Neurology. 12(1). 10–17. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact